TVM Life Science Ventures VI LP
Insider CIK 1318584 · ACER Director, 10% owner · PRTO Director, 10% owner · CNCE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACER Acer Therapeutics Inc. | P Buy | 2017-12-12 | 2018-01-12 | 21,271 | $12.00 | $255.3K | 248,756 | SEC↗ |
| ACER Acer Therapeutics Inc. | P Buy | 2017-12-12 | 2018-01-12 | 250,000 | $12.00 | $3.00M | 1,422,709 | SEC↗ |
| ACER Acer Therapeutics Inc. | P Buy | 2017-12-12 | 2018-01-12 | 62,062 | $12.00 | $744.7K | 725,844 | SEC↗ |
| ACER Acer Therapeutics Inc. | J Other | 2017-09-19 | 2017-09-27 | 227,485 | — | $0 | 227,485 | SEC↗ |
| ACER Acer Therapeutics Inc. | J Other | 2017-09-19 | 2017-09-27 | 1,172,709 | — | $0 | 1,172,709 | SEC↗ |
| ACER Acer Therapeutics Inc. | J Other | 2017-09-19 | 2017-09-27 | 663,782 | — | $0 | 663,782 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy deriv | 2017-06-22 | 2017-06-26 | 128 | $1000.00 | $128.0K | 500 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy deriv | 2017-06-22 | 2017-06-26 | 372 | $1000.00 | $372.0K | 500 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy deriv | 2017-06-22 | 2017-06-30 | 372 | $1000.00 | $372.0K | 500 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-30 | 799,043 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-30 | 1,531,518 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-30 | 2,092,735 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-30 | 717,260 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-30 | 2,436,618 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-30 | 835,121 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-30 | 2,331,391 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2014-10-27 | 2014-10-30 | 451,276 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-30 | 3,727,823 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-30 | 1,277,663 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise deriv | 2014-10-27 | 2014-10-30 | 116,511 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise deriv | 2014-10-27 | 2014-10-30 | 39,932 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2014-10-27 | 2014-10-30 | 1,316,683 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-30 | 4,468,482 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise | 2014-10-27 | 2014-10-30 | 39,932 | $4.60 | $183.7K | 1,943,059 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise | 2014-10-27 | 2014-10-30 | 116,511 | $4.60 | $536.0K | 1,903,127 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-30 | 379,462 | — | $0 | 1,786,616 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-30 | 1,107,154 | — | $0 | 1,407,154 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-30 | 76,590 | $10.00 | $765.9K | 300,000 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-30 | 223,410 | $10.00 | $2.23M | 223,410 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-20 | 841,493 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-20 | 1,638,450 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-20 | 3,165,187 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-20 | 288,407 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-20 | 1,084,813 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-20 | 561,550 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-20 | 148,936 | — | $0 | 1,038,682 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-20 | 22,713 | $14.00 | $318.0K | 378,703 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-20 | 66,287 | $14.00 | $928.0K | 1,104,969 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-20 | 51,045 | — | $0 | 355,990 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-20 | 192,003 | — | $0 | 304,945 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-20 | 99,389 | — | $0 | 112,942 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-20 | 560,211 | — | $0 | 889,746 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-20 | 289,991 | — | $0 | 329,535 | SEC↗ |